American Well Co. (NYSE:AMWL) Holdings Lowered by Vanguard Group Inc.

Vanguard Group Inc. trimmed its stake in shares of American Well Co. (NYSE:AMWL) by 20.7% in the 3rd quarter, HoldingsChannel reports. The firm owned 17,411,299 shares of the company’s stock after selling 4,549,856 shares during the quarter. Vanguard Group Inc. owned approximately 0.06% of American Well worth $20,371,000 at the end of the most recent quarter.

Several other hedge funds have also modified their holdings of AMWL. GSA Capital Partners LLP lifted its stake in American Well by 75.5% in the 3rd quarter. GSA Capital Partners LLP now owns 716,830 shares of the company’s stock worth $839,000 after acquiring an additional 308,418 shares in the last quarter. Versor Investments LP purchased a new stake in American Well in the 3rd quarter worth about $294,000. Quadrature Capital Ltd purchased a new stake in American Well in the 3rd quarter worth about $36,000. Barclays PLC raised its stake in shares of American Well by 8.8% during the 3rd quarter. Barclays PLC now owns 173,359 shares of the company’s stock worth $203,000 after purchasing an additional 14,021 shares in the last quarter. Finally, Swiss National Bank raised its stake in shares of American Well by 2.3% during the 3rd quarter. Swiss National Bank now owns 463,200 shares of the company’s stock worth $542,000 after purchasing an additional 10,500 shares in the last quarter. 56.05% of the stock is owned by hedge funds and other institutional investors.

American Well Price Performance

AMWL opened at $0.58 on Monday. American Well Co. has a fifty-two week low of $0.57 and a fifty-two week high of $2.74. The business has a 50-day moving average of $0.96 and a 200-day moving average of $1.12. The company has a market capitalization of $166.41 million, a PE ratio of -0.24 and a beta of 0.99.

American Well (NYSE:AMWL) last posted its quarterly earnings results on Wednesday, February 14th. The company reported ($0.17) earnings per share for the quarter, topping analysts’ consensus estimates of ($0.19) by $0.02. American Well had a negative return on equity of 40.19% and a negative net margin of 260.63%. The company had revenue of $70.68 million during the quarter, compared to the consensus estimate of $70.16 million. During the same period last year, the business earned ($0.22) EPS. The business’s quarterly revenue was down 10.8% on a year-over-year basis. On average, equities research analysts expect that American Well Co. will post -0.7 earnings per share for the current fiscal year.

Insider Transactions at American Well

In other news, EVP Vukasin Paunovich sold 58,409 shares of the firm’s stock in a transaction dated Tuesday, January 16th. The stock was sold at an average price of $1.07, for a total transaction of $62,497.63. Following the completion of the sale, the executive vice president now directly owns 615,312 shares of the company’s stock, valued at approximately $658,383.84. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. In other news, CFO Robert Shepardson sold 319,214 shares of the stock in a transaction dated Friday, February 23rd. The stock was sold at an average price of $1.09, for a total transaction of $347,943.26. Following the transaction, the chief financial officer now owns 2,845,148 shares of the company’s stock, valued at approximately $3,101,211.32. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, EVP Vukasin Paunovich sold 58,409 shares of the stock in a transaction dated Tuesday, January 16th. The shares were sold at an average price of $1.07, for a total value of $62,497.63. Following the transaction, the executive vice president now directly owns 615,312 shares in the company, valued at approximately $658,383.84. The disclosure for this sale can be found here. Insiders sold 1,227,447 shares of company stock valued at $1,329,908 in the last three months. Corporate insiders own 12.94% of the company’s stock.

American Well Profile

American Well Corporation, an enterprise platform and software company, delivers digitally enabling hybrid care in the United States and internationally. The company offers Converge, a cloud-based platform that enables health providers, payers, and innovators to provide in-person, virtual and automated care; and delivers virtual primary care, post-discharge follow-up, chronic condition management, virtual nursing, e-sitting, on-demand and scheduled virtual visits, specialty consults, automated care, and behavioral health, as well as specialty care programs, including dermatology, musculoskeletal care, second opinion, and cardiometabolic care to patients and members.